Brooke Hayward

2.8k total citations
63 papers, 1.2k citations indexed

About

Brooke Hayward is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Reproductive Medicine. According to data from OpenAlex, Brooke Hayward has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 17 papers in Public Health, Environmental and Occupational Health and 16 papers in Reproductive Medicine. Recurrent topics in Brooke Hayward's work include Multiple Sclerosis Research Studies (17 papers), Reproductive Health and Technologies (14 papers) and Reproductive Biology and Fertility (10 papers). Brooke Hayward is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Reproductive Health and Technologies (14 papers) and Reproductive Biology and Fertility (10 papers). Brooke Hayward collaborates with scholars based in United States, Germany and Italy. Brooke Hayward's co-authors include Paul Van Eerdewegh, Kathryn L. Lunetta, Jonathan Segal, Josée Dupuis, Kathleen Falls, Alexandre Bureau, Tim P. Keith, M.C. Mahony, Mark Small and Fernando Dangond and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Brooke Hayward

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brooke Hayward United States	14	423	317	120	114	98	63	1.2k
Luisa Bernardinelli Italy	24	278 0.7×	320 1.0×	190 1.6×	448 3.9×	179 1.8×	96	2.6k
J. Wade Davis United States	24	1.2k 2.7×	393 1.2×	117 1.0×	173 1.5×	88 0.9×	67	2.2k
Gad Abraham Australia	18	511 1.2×	1.0k 3.3×	115 1.0×	236 2.1×	117 1.2×	25	1.9k
Bowang Chen Germany	23	734 1.7×	400 1.3×	94 0.8×	183 1.6×	195 2.0×	70	1.9k
Laurent Briollais Canada	24	799 1.9×	500 1.6×	241 2.0×	170 1.5×	208 2.1×	92	1.9k
Roman Kosoy United States	16	425 1.0×	594 1.9×	162 1.4×	112 1.0×	40 0.4×	30	1.3k
Hyun Jun Park South Korea	24	408 1.0×	99 0.3×	219 1.8×	80 0.7×	123 1.3×	207	2.1k
Enrique Vidal Spain	28	1.5k 3.5×	499 1.6×	136 1.1×	88 0.8×	71 0.7×	52	2.3k
Kevin B. Jacobs United States	21	842 2.0×	1.3k 4.2×	86 0.7×	100 0.9×	152 1.6×	52	2.4k
Vajira H. W. Dissanayake Sri Lanka	16	384 0.9×	315 1.0×	207 1.7×	102 0.9×	62 0.6×	153	1.3k

Countries citing papers authored by Brooke Hayward

Since Specialization

Citations

This map shows the geographic impact of Brooke Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke Hayward more than expected).

Fields of papers citing papers by Brooke Hayward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brooke Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke Hayward. The network helps show where Brooke Hayward may publish in the future.

Co-authorship network of co-authors of Brooke Hayward

This figure shows the co-authorship network connecting the top 25 collaborators of Brooke Hayward. A scholar is included among the top collaborators of Brooke Hayward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brooke Hayward. Brooke Hayward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wohlfeiler, Michael, Rachel Palmieri Weber, Laurence Brunet, et al.. (2023). Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort. AIDS Research and Human Retroviruses. 39(12). 636–643.

Brownlee, Wallace, Aiden Haghikia, Brooke Hayward, et al.. (2023). Comparative effectiveness of cladribine tablets versus fingolimod in the treatment of highly active multiple sclerosis: A real-world study. Multiple Sclerosis and Related Disorders. 76. 104791–104791. 4 indexed citations

Beall, Stephanie, G. David Ball, Brooke Hayward, et al.. (2023). Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis. Frontiers in Endocrinology. 14. 1195632–1195632. 1 indexed citations

Bielfeld, Alexandra P., Juan-Enrique Schwarze, Patrice Verpillat, et al.. (2023). Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years. Reproductive BioMedicine Online. 48(6). 103725–103725. 2 indexed citations

Brownlee, Wallace, Aiden Haghikia, Brooke Hayward, et al.. (2022). Comparative Effectiveness of Cladribine versus Fingolimod in the Treatment of Highly Active Relapsing Multiple Sclerosis: The MERLYN (MavEnclad Real worLd comparative efficacY non-iNterventional) Study (P7-4.005). Neurology. 98(18_supplement). 1 indexed citations

Miravalle, Augusto, Joshua Katz, Derrick Robertson, et al.. (2021). CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis. Neurodegenerative Disease Management. 11(2). 99–111. 6 indexed citations

Hayward, Brooke, et al.. (2021). SHIFTS IN ART CLINICAL PRACTICE – NAVIGATING CYCLE DEFINITIONS AND POTENTIAL IMPLICATION ON FERTILITY TREATMENT COVERAGE IN THE UNITED STATES. Fertility and Sterility. 116(1). e11–e11.

Holmes, Rebecca, et al.. (2021). Comparison of electronic versus manual witnessing of procedures within the in vitro fertilization laboratory: impact on timing and efficiency. F&S Reports. 2(2). 181–188. 11 indexed citations

Wu, Gregory F., Ursula Boschert, Brooke Hayward, et al.. (2020). CLOCK-MS: Evaluating the Mechanism of Action of Cladribine Tablets via CNS and Blood Biomarkers in MS (4196). Neurology. 94(15_supplement). 1 indexed citations

10.

Freedman, Mark S., Staley A. Brod, B. Singer, et al.. (2019). Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS. Journal of Neurology. 267(1). 64–75. 4 indexed citations

11.

Mahony, M.C., et al.. (2019). Infertility patient clinical journey outcome depends on initial treatment, starting with ovulation induction (OI) vs in vitro fertilization (IVF): results from a large real-world database. Fertility and Sterility. 112(3). e396–e397. 1 indexed citations

12.

Collura, Barbara, et al.. (2019). Insights into infertility patient discontinuation of care: results of a nationwide survey. Fertility and Sterility. 112(3). e397–e398. 2 indexed citations

13.

Hayward, Brooke, et al.. (2017). My Home is My Marae: Kaupapa Māori evaluation of an approach to injury prevention. BMJ Open. 7(3). e013811–e013811. 7 indexed citations

14.

Hayward, Brooke, et al.. (2017). Increasing patient engagement in healthcare service design: a qualitative evaluation of a co-design programme in New Zealand. Patient Experience Journal. 4(1). 23–32. 26 indexed citations

15.

Mangili, Alexandra, et al.. (2015). Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat. PLoS ONE. 10(10). e0140358–e0140358. 6 indexed citations

16.

Dwyer, Michael G., Robert Zivadinov, Yazhong Tao, et al.. (2015). Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial. BMC Neurology. 15(1). 232–232. 12 indexed citations

17.

Recht, Michael, László Nemes, Michał Matysiak, et al.. (2009). Clinical evaluation of moroctocog alfa (AF‐CC), a new generation of B‐domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full‐length recombinant factor VIII. Haemophilia. 15(4). 869–880. 67 indexed citations

18.

Lunetta, Kathryn L., Brooke Hayward, Jonathan Segal, & Paul Van Eerdewegh. (2004). Screening large-scale association study data: exploiting interactions using random forests. BMC Genetics. 5(1). 32–32. 363 indexed citations

19.

Bureau, Alexandre, Josée Dupuis, Brooke Hayward, Kathleen Falls, & Paul Van Eerdewegh. (2003). Mapping complex traits using Random Forests. BMC Genetics. 4(S1). S64–S64. 52 indexed citations

20.

Small, Mark, et al.. (1989). Client Demographics and Outcome in Outpatient Cocaine Treatment. International Journal of the Addictions. 24(8). 765–783. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact